Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CSN5i-3 is a novel potent oral and selective CSN5/Jab1 inhibitor that inhibits CSN-catalyzed Cul1 deneddylation with an IC50 value of 5.8 nM.CSN5i-3 exhibits anticancer activity, inhibits cell proliferation and induces apoptosis in human breast cancer cells.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 87,000 |
5 mg | 在庫あり | ¥ 186,500 |
10 mg | 在庫あり | ¥ 282,500 |
25 mg | 在庫あり | ¥ 420,000 |
50 mg | 在庫あり | ¥ 567,000 |
100 mg | 在庫あり | ¥ 764,500 |
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 203,500 |
説明 | CSN5i-3 is a novel potent oral and selective CSN5/Jab1 inhibitor that inhibits CSN-catalyzed Cul1 deneddylation with an IC50 value of 5.8 nM.CSN5i-3 exhibits anticancer activity, inhibits cell proliferation and induces apoptosis in human breast cancer cells. |
ターゲット&IC50 | CSN5:5.8 nM |
In vitro | CSN5i-3, by trapping CRLs in the neddylation state, effectively causes the inactivation of a specific subset of CRLs through the induction of degradation in their substrate recognition module.[1] |
In vivo | CSN5i-3 exhibits a favorable pharmacokinetic profile, and its application results in the formation of cleaved PARP and cleaved caspase 3, indicating the initiation of apoptosis.[1] |
分子量 | 505.56 |
分子式 | C28H29F2N5O2 |
CAS No. | 2375740-98-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 75.83 mg/mL (150 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CSN5i-3 2375740-98-8 Apoptosis Others CSN5i3 CSN-5i-3 CSN5i 3 Inhibitor inhibitor inhibit